Patents by Inventor Harry Abts

Harry Abts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins
    Patent number: 9133485
    Abstract: The invention lies in the field of production of recombinant gene products in eukaryotic cells. The invention refers to methods and materials for the fast and reproducible generation of production cells lines suitable for large scale production of recombinant gene products. The invention encompasses specific vector systems, genetic engineered host-cells and methods of use.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: September 15, 2015
    Assignee: Celonic AG
    Inventors: Andreas Herrmann, Harry Abts, Benedikt Greulich
  • GEL FORMULATIONS FOR THE TOPICAL USE OF 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES
    Publication number: 20130165522
    Abstract: This invention provides a pharmaceutical composition for topical application to the skin of a patient in need of, comprising neramexane or a pharmaceutically acceptable salt thereof, and at least one gel forming agent for the treatment or prevention of inflammatory skin diseases such as impetigo contagiosa, acne, rosacea, eczema, atopic dermatitis, contact dermatitis, seborrheic dermatitis, psoriasis, and/or oily skin. The at least one gel forming agent comprises polymers with neutral and/or positively charged polymer backbones.
    Type: Application
    Filed: June 17, 2011
    Publication date: June 27, 2013
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Petra Scheppler, Bernhard Hauptmeier, Alexander Linko, Harry Abts
  • USE OF A CATIONIC AMPHIPHILIC DRUG FOR THE PREPARATION OF A FORMULATION FOR THE REDUCTION OF SUBCUTANEOUS ADIPOSE TISSUE
    Publication number: 20130143869
    Abstract: Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction and/or prevention of subcutaneous adipose tissue with improved effectiveness and better reproducible activity.
    Type: Application
    Filed: July 14, 2011
    Publication date: June 6, 2013
    Applicant: Merz Pharma GmbH & CO. KGaA
    Inventors: Kevin Kiehm, Bernhard Hauptmeier, Harry Abts, Peter Boderke
  • METHODS AND MATERIALS FOR THE REPRODUCIBLE GENERATION OF HIGH PRODUCER CELL LINES FOR RECOMBINANT PROTEINS
    Publication number: 20110008895
    Abstract: The invention lies in the field of production of recombinant gene products in eukaryotic cells. The invention refers to methods and materials for the fast and reproducible generation of production cells lines suitable for large scale production of recombinant gene products. The invention encompasses specific vector systems, genetic engineered host-cells and methods of use.
    Type: Application
    Filed: March 27, 2009
    Publication date: January 13, 2011
    Applicant: CELONIC AG
    Inventors: Andreas Herrmann, Harry Abts, Benedikt Greulich
  • Methods and cell populations for identifying and validating genomic targets, and for drug screening
    Publication number: 20050191693
    Abstract: This invention relates to isolated, stem-cell derived cell populations and methods of use thereof. Methods of use include genomic target identification, validation of conventionally obtained genomic targets using e.g. expression profiling, positional cloning and/or transgenic animals, lineage-specific and/or transgene-specific drug screening and pharmacogenomics analysis.
    Type: Application
    Filed: April 8, 2005
    Publication date: September 1, 2005
    Inventors: Loren Field, Manfred Rudiger, Michael Ruhl, Harry Abts, Hilmar Schiller
  • Methods and cell populations for identifying and validating genomic targets, and for drug screening
    Publication number: 20030108895
    Abstract: This invention relates to isolated, stem-cell derived cell populations and methods of use thereof. Methods of use include genomic target identification, validation of conventionally obtained genomic targets using e.g. expression profiling, positional cloning and/or transgenic animals, lineage-specific and/or transgene-specific drug screening and pharmacogenomics analysis.
    Type: Application
    Filed: June 19, 2002
    Publication date: June 12, 2003
    Inventors: Loren J. Field, Manfred Rudiger, Michael Ruhl, Harry Abts, Hilmar Schiller